Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

CLRB.US Logo

CLRB.US - Current Price

$3.80

Company Information

Company Name
Cellectar Biosciences Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US15117F8077
CIK: 0001279704
CUSIP: 67000M100
Currency: USD
Full Time Employees: 11
Phone: 608 441 8120
Fiscal Year End: December
IPO Date: Nov 10, 2005
Description:

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States. The company's lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. It also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChem Bio. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Florham Park, New Jersey.

Address:

100 Campus Drive, Florham Park, NJ, United States, 07932

Directors & Officers

Name Title Year Born
Mr. James V. Caruso President, CEO & Director 1959
Mr. Chad J. Kolean CPA VP, CFO & Secretary 1964
Mr. Jarrod Longcor Chief Operating Officer 1973

Shares Statistics

Shares Outstanding: 4.24M
Shares Float: 4.06M
% Insiders: 450.00%
% Institutions: 708.10%
Short % Float: 2.50%

Valuation Metrics

Enterprise Value: $4.51M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $16.11M
EBITDA: $-29.80M
PEG Ratio: $0.00
Book Value: $2.34
Earnings/Share: $-8.07
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -72.31%
ROE (TTM): -145.42%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

Date EPS Actual EPS Estimate Difference Surprise %
Sep 30, 2025 -1.41 -0.14 N/A -91,731.60%
Jun 30, 2025 -3.39 -0.13 N/A -244,887.22%
Mar 31, 2025 -0.14 -0.16 N/A 1,224.74%
Dec 31, 2024 -0.01 -0.35 N/A 9,716.31%
Sep 30, 2024 -0.37 -0.37 N/A 88.40%
Jun 30, 2024 -0.32 -0.30 N/A -666.67%
Mar 31, 2024 -0.74 -0.56 N/A -3,214.29%
Dec 31, 2023 -0.61 -0.57 N/A -701.75%
Sep 30, 2023 -0.83 -0.52 N/A -5,961.54%
Jun 30, 2023 -0.73 -0.64 N/A -1,406.25%
Mar 31, 2023 -0.76 -0.87 N/A 1,264.37%
Dec 31, 2022 -0.55 -1.07 N/A 4,859.81%
Sep 30, 2022 -1.28 -1.21 N/A -578.51%
Jun 30, 2022 -1.22 -1.03 N/A -1,844.66%
Mar 31, 2022 -1.00 -1.00 N/A 0.00%
Dec 31, 2021 -0.90 -1.02 N/A 1,176.47%
Sep 30, 2021 -1.00 -1.10 N/A 909.09%
Jun 30, 2021 -1.10 -1.15 N/A 434.78%
Mar 31, 2021 -1.30 -1.02 N/A -2,745.10%
Dec 31, 2020 -0.70 -1.46 N/A 5,205.48%
Sep 30, 2020 -1.50 -2.00 N/A 2,500.00%
Jun 30, 2020 -2.60 -2.96 N/A 1,216.22%
Mar 31, 2020 -4.20 -3.47 N/A -2,103.75%
Dec 31, 2019 -3.30 -3.70 N/A 1,081.08%
Sep 30, 2019 -4.20 -3.80 N/A -1,052.63%
Jun 30, 2019 -4.60 -6.95 N/A 3,381.29%
Mar 31, 2019 -7.60 -7.40 N/A -270.27%
Dec 31, 2018 -6.20 -10.00 N/A 3,800.00%
Sep 30, 2018 -16.50 -8.30 N/A -9,879.52%
Jun 30, 2018 -16.90 -21.00 N/A 1,952.38%
Mar 31, 2018 -21.00 -20.00 N/A -500.00%
Dec 31, 2017 -34.00 -23.00 N/A -4,782.61%
Sep 30, 2017 -26.00 -25.00 N/A -400.00%
Jun 30, 2017 -23.00 -24.00 N/A 416.67%
Mar 31, 2017 -24.00 -23.00 N/A -434.78%
Dec 31, 2016 -34.00 -23.00 N/A -4,782.61%
Sep 30, 2016 -43.00 -20.00 N/A -11,500.00%
Jun 30, 2016 -49.00 -40.00 N/A -2,250.00%
Mar 31, 2016 -0.49 N/A N/A N/A
Dec 31, 2015 -0.50 N/A N/A N/A
Sep 30, 2015 -0.50 N/A N/A N/A
Jun 30, 2015 -0.05 N/A N/A N/A
Mar 31, 2015 -0.05 N/A N/A N/A
Dec 31, 2014 -34.00 N/A N/A N/A
Sep 30, 2014 -0.05 N/A N/A N/A
Jun 30, 2014 -21.81K N/A N/A N/A
Mar 31, 2014 -30.77K N/A N/A N/A
Dec 31, 2013 -41.28K N/A N/A N/A
Sep 30, 2013 -13.75K N/A N/A N/A
Jun 30, 2013 -21.58K N/A N/A N/A
Mar 31, 2013 -40.41K N/A N/A N/A
Dec 31, 2012 -100.00 -100.00 N/A 0.00%
Sep 30, 2012 -120.00 -100.00 N/A -2,000.00%
Jun 30, 2012 -120.00 -120.00 N/A 0.00%
Mar 31, 2012 -38.31K N/A N/A N/A
Dec 31, 2011 -120.00 -100.00 N/A -2,000.00%
Sep 30, 2011 -42.70K N/A N/A N/A
Jun 30, 2011 -60.49K N/A N/A N/A
Mar 31, 2011 -204.88K N/A N/A N/A
Dec 31, 2010 -1,000.00K N/A N/A N/A
Sep 30, 2010 -1,000.00K N/A N/A N/A
Jun 30, 2010 -1,000.00K N/A N/A N/A
Mar 31, 2010 -6.12K -15.30K N/A 6,000.00%
Dec 31, 2009 -79.56K -16.83K N/A -37,272.73%
Sep 30, 2009 -1,000.00K N/A N/A N/A
Jun 30, 2009 -39.78K -19.89K N/A -10,000.00%
Mar 31, 2009 -21.42K -27.54K N/A 2,222.22%
Dec 31, 2008 -1,000.00K N/A N/A N/A
Sep 30, 2008 -21.42K -42.84K N/A 5,000.00%
Jun 30, 2008 -1,000.00K N/A N/A N/A
Mar 31, 2008 -58.14K -39.78K N/A -4,615.38%
Dec 31, 2007 -55.08K -53.55K N/A -285.71%
Sep 30, 2007 -52.02K -39.78K N/A -3,076.92%
Jun 30, 2007 -104.04K -36.72K N/A -18,333.33%
Mar 31, 2007 -1,000.00K N/A N/A N/A
Dec 31, 2006 -21.42K -27.54K N/A 2,222.22%
Sep 30, 2006 -1,000.00K N/A N/A N/A
Jun 30, 2006 -1,000.00K N/A N/A N/A
Mar 31, 2006 -1,000.00K N/A N/A N/A
Dec 31, 2005 -1,000.00K N/A N/A N/A
Sep 30, 2005 -12.24K -12.24K N/A 0.00%
Jun 30, 2005 -1,000.00K N/A N/A N/A

Balance Sheet (Yearly)

Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $23.29M $N/A $25.47M $11.18M $14.29M
2023-12-31 $9.56M $N/A $12.08M $25.85M $-13.78M
2022-12-31 $19.87M $N/A $21.59M $12.05M $9.54M
2021-12-31 $35.70M $N/A $37.20M $4.16M $33.05M
2020-12-31 $57.17M $N/A $58.66M $3.86M $54.79M
2019-12-31 $10.61M $N/A $12.25M $3.19M $9.06M
2018-12-31 $13.26M $N/A $15.05M $1.79M $13.26M
2017-12-31 $10.01M $N/A $12.87M $2.12M $10.75M
2016-12-31 $11.44M $N/A $15.32M $1.78M $13.54M
2015-12-31 $3.86M $N/A $7.60M $5.95M $1.65M
2014-12-31 $9.42M $N/A $13.42M $2.67M $10.75M
2013-12-31 $2.42M $N/A $6.82M $5.12M $1.70M
2012-12-31 $4.68M $N/A $11.48M $1.32M $10.16M
2011-12-31 $5.51M $N/A $10.56M $1.08M $9.48M
2010-12-31 $2.37M $N/A $2.46M $1.25M $1.21M
2009-12-31 $8.77M $N/A $8.93M $35.83M $-26.90M
2008-12-31 $1.26M $N/A $1.47M $7.05M $-5.58M
2007-12-31 $9.74M $N/A $11.11M $16.98M $-5.87M
2006-12-31 $9.94M $N/A $11.92M $1.31M $10.61M
2005-12-31 $4.27M $N/A $4.94M $217.16K $4.72M
2004-12-31 $10.36K $N/A $108.57K $4.46M $-4.35M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jul 02, 2025 N/A N/A N/A N/A N/A N/A
Jul 02, 2025 N/A N/A N/A N/A N/A N/A
Jul 02, 2025 N/A N/A N/A N/A N/A N/A
Jan 10, 2025 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist